Miranti CK - Search Results

1

Cancer Cell-Extrinsic Roles for the Androgen Receptor in Prostate Cancer.

Hahn AW, Siddiqui BA, Leo J, Dondossola E, Basham KJ, Miranti CK, Frigo DE. Hahn AW, et al. Among authors: miranti ck. Endocrinology. 2023 Apr 17;164(6):bqad078. doi: 10.1210/endocr/bqad078. Endocrinology. 2023. PMID: 37192413 Free PMC article. Review.

2

Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex.

Miranti CK, Moore S, Kim Y, Chappeta VR, Wu K, De B, Gokhale V, Hurley LH, Reyes-Reyes EM. Miranti CK, et al. Oncotarget. 2020 May 12;11(19):1758-1776. doi: 10.18632/oncotarget.27589. eCollection 2020 May 12. Oncotarget. 2020. PMID: 32477465 Free PMC article.

3

Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer.

Nollet EA, Cardo-Vila M, Ganguly SS, Tran JD, Schulz VV, Cress A, Corey E, Miranti CK. Nollet EA, et al. Among authors: miranti ck. Oncogene. 2020 Jul;39(31):5390-5404. doi: 10.1038/s41388-020-1370-9. Epub 2020 Jun 21. Oncogene. 2020. PMID: 32565538 Free PMC article.

4

AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production.

Tahsin S, Sane NS, Cernyar B, Jiang L, Zohar Y, Lee BR, Miranti CK. Tahsin S, et al. Among authors: miranti ck. Oncogene. 2024 May 20. doi: 10.1038/s41388-024-03064-7. Online ahead of print. Oncogene. 2024. PMID: 38769192

5

Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.

Zarif JC, Lamb LE, Schulz VV, Nollet EA, Miranti CK. Zarif JC, et al. Among authors: miranti ck. Oncotarget. 2015 Mar 30;6(9):6862-76. doi: 10.18632/oncotarget.3119. Oncotarget. 2015. PMID: 25730905 Free PMC article.

6

Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.

Rubenstein CS, Gard JMC, Wang M, McGrath JE, Ingabire N, Hinton JP, Marr KD, Simpson SJ, Nagle RB, Miranti CK, Warfel NA, Garcia JGN, Arif-Tiwari H, Cress AE. Rubenstein CS, et al. Among authors: miranti ck. Cancer Res. 2019 Sep 15;79(18):4703-4714. doi: 10.1158/0008-5472.CAN-19-0868. Epub 2019 Jul 23. Cancer Res. 2019. PMID: 31337652 Free PMC article.

7

Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.

Ganguly SS, Hostetter G, Tang L, Frank SB, Saboda K, Mehra R, Wang L, Li X, Keller ET, Miranti CK. Ganguly SS, et al. Among authors: miranti ck. Oncogene. 2020 Jan;39(1):204-218. doi: 10.1038/s41388-019-0977-1. Epub 2019 Aug 29. Oncogene. 2020. PMID: 31467432 Free PMC article.

8

Aberrant CREB1 activation in prostate cancer disrupts normal prostate luminal cell differentiation.

Watson MJ, Berger PL, Banerjee K, Frank SB, Tang L, Ganguly SS, Hostetter G, Winn M, Miranti CK. Watson MJ, et al. Among authors: miranti ck. Oncogene. 2021 May;40(18):3260-3272. doi: 10.1038/s41388-021-01772-y. Epub 2021 Apr 12. Oncogene. 2021. PMID: 33846571 Free PMC article.

9

The androgen receptor induces integrin α6β1 to promote prostate tumor cell survival via NF-κB and Bcl-xL Independently of PI3K signaling.

Lamb LE, Zarif JC, Miranti CK. Lamb LE, et al. Among authors: miranti ck. Cancer Res. 2011 Apr 1;71(7):2739-49. doi: 10.1158/0008-5472.CAN-10-2745. Epub 2011 Feb 10. Cancer Res. 2011. PMID: 21310825 Free PMC article.

10

Erratum: Nucleolin represses transcription of the androgen receptor gene through a G-quadruplex.

Miranti CK, Moore S, Kim Y, Chappeta VR, Wu K, De B, Gokhale V, Hurley LH, Reyes-Reyes EM. Miranti CK, et al. Oncotarget. 2020 Jun 30;11(26):2586. doi: 10.18632/oncotarget.27661. eCollection 2020 Jun 30. Oncotarget. 2020. PMID: 32655842 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55 results

Search Page